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Objectives: Diabetic eye disease is the most common
cause of visual loss in adults, and proliferative diabetic
retinopathy (PDR) is the main cause of blindness. This
study aimed to determine the predisposing factors for
PDR that were identified by fundus photography
among patients with type 2 diabetes mellitus (DM) at
the Diabetic Clinic at Hospital Universiti Sains
Malaysia.
Methods: In this retrospective study, fundus photo re-
view was performed on patients with type 2 DM who had
undergone diabetic retinopathy screening using a non-
mydriatic fundus camera from January 2008 until
December 2012. Fundus photos were classified into 2
groups, PDR and no apparent diabetic retinopathy (no
DR). Socio-demographic data and clinical and metabolic
profiles were obtained from the medical records. Logistic
regression was used to determine the factors associated
with PDR.y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.03.002
M.H. Mohd Ali et al.354Results: A total of 120 patients were selected, with 30
patients in the PDR group and 90 patients in the no DR
group. The mean age of patients with PDR was 52 (7.94)
years and was 58 (12.31) years in the no DR group.
Hypertension and hyperlipidaemia were the most com-
mon comorbidities identified in this study. The HbA1c
level >6.5% and LDL level >2.6 mmol/L were higher in
the PDR group. Age (p ¼ 0.032), duration of DM
(p ¼ 0.022), nephropathy (p ¼ 0.002) and peripheral
neuropathy (p ¼ 0.001) were significantly associated with
PDR.
Conclusion: The significant predictors of PDR among
patients with type 2 DM as detected by fundus photog-
raphy were age, duration of DM, nephropathy and pe-
ripheral neuropathy.
Keywords: Diabetic peripheral neuropathy; Fundus photo
review; Fundus photography; Hypertension; Proliferative
diabetic retinopathy
 2016 The Authors.
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NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Diabetic retinopathy can be present at the time of diagnosis
of type 2 diabetesmellitus (T2DM)due to the insidiousonset of
the disease, as documented in theUnitedKingdomProspective
Diabetes Study (UKPDS), in which 39% of men and 35% of
women had retinopathy at the time of diagnosis.1 Diabetic
retinopathy is a microvascular complication that results from
prolonged uncontrolled diabetes mellitus (DM).2 Diabetic
retinopathy can be graded into categories of no apparent
diabetic retinopathy (no DR), non-proliferative diabetic reti-
nopathy (NPDR), proliferative diabetic retinopathy (PDR)
and advance diabetic eye disease (ADED).3 PDR and ADED
aremajor causes of blindness among patientswithDMand are
associated with an increased risk of cardiovascular disease,
diabetic nephropathy and mortality.4
The occurrence of PDR is due to progressive retinal
ischemia leading to vision loss, traction retinal detachment
and vitreous haemorrhage.5 Early detection of vision loss
and blindness resulting from diabetic retinopathy is
important as it is reversible.3 Therefore, an annual eye
examination is recommended for patients with DM.
Despite this recommendation, according to the National
Health Malaysian Survey (NHMS) III 2006 findings, only
45% of patients with DM had undergone an eye
examination at least once after their diagnosis of diabetes.6
The prevalence of diabetic retinopathy in Malaysia has
been reported to range from 44.1%7 to 48.6%.8 Other studies
have shown that the prevalence of diabetic retinopathy in
Malaysia is 12.3% for Type 1 DM and 22.3% for Type 2
DM.9 Most published Malaysian data are primarily
hospital-based.9e11 Nevertheless, the prevalence of PDR
varies from 2.0% for patients who had diabetes for lessthan 5 years to 15.5% for patients who had diabetes for 15
years or more.4 In Malaysia, the 2007 Diabetic Eye Registry
reported a prevalence of PDR of 7.1%.12 Meanwhile, a
recent study conducted in a primary care setting on Borneo
Island in 2011 reported a prevalence of PDR of 3.2%.13
Many risk factors for PDR have been identified, such as
elevated glycosylated haemoglobin A1c (HbA1c), elevated
diastolic and systolic blood pressure, increased duration of
diabetes, the severity of retinopathy at baseline, increased
waist-to-hip ratio and the onset of type 1 DM before pu-
berty.14 PDR is unavoidable and develops irrespective of
pharmacological treatment of DM and hypertension. Most
published Malaysian data primarily focus on diabetic
retinopathy as a whole rather than considering its different
stages. In this study, we focused on patients with PDR
who were identified during diabetic retinopathy screening
using a non-mydriatic fundus camera with the aim of
determining the associating factors among PDR patients.
These data will provide useful local information regarding
PDR and create awareness about the severity of PDR among
patients with type 2 DM.Materials and Methods
This was a retrospective record review of fundus photos
from patients with type 2 DM at the Diabetic Clinic, Hos-
pital Universiti Sains Malaysia (HUSM) from January 2008
until December 2012. All patients with diabetes who were
referred to the Diabetic Clinic were screened for diabetic
retinopathy using a non-mydriatic fundus camera. Patients
who were more than 18 years old with type 2 DM and who
were diagnosed with PDR on the fundus photograph were
selected. Patients with Type 1 DM, NPDR, ADED, glau-
coma, cataract, retinal vaso-occlusive disease, or poor
fundus view or had images due to opaque media and retinal
disease were excluded.
The definition for PDR was based on the International
ClinicalDiabeticRetinopathy andDiabeticMacularOedema
Disease Severity Scale,3 which consist of one of the following:
i) Neo-vascularisation
ii) Vitreous/preretinal haemorrhage
For the study group (PDR group), either unilateral or
bilateral PDR features on fundus photography were included
in the study, while, for the control group, only a bilateral
normal fundus was considered for simple random sampling.
The screening process for the study group was based on
cases that were diagnosed one year before or after the first
fundus photography result. This is because many of the diag-
nostic tests were not routinely performed in the study centre.
Diabetic nephropathy was diagnosed based on the pres-
ence of proteinuria determined by a positive dipstick on 2
separate occasions, 1 year before or after the first fundus
photography. The urinary albumin creatinine (UACR) ratio
test is not routinely performed in the study centre.
Diabetic neuropathy is recognized by the American Dia-
betes Association (ADA) as the presence of symptoms and/
or signs of peripheral nerve dysfunction in people with dia-
betes after the exclusion of other causes.15 In this study, any
documentation regarding numbness and/or abnormal
Table 1: Socio-demographic data of type 2 DM patients with
no DR and PDR group.
Variables No DR (n ¼ 90) PDR (n ¼ 30)
n (%) n (%)
Age (years) 57 (12.3)a 52 (7.9)a
Gender
Male 49 (54.4) 14 (46.7)
Female 41 (45.6) 16 (53.3)
Race
Non Malay 17 (18.9) 5 (16.7)
Malay 73 (81.1) 25 (83.3)
Smoking
Nonsmoker 76 (84.4) 20 (66.7)
Smoker 14 (15.6) 10 (33.3)
Duration
10 years 62 (68.9) 12 (40.0)
>10 years 28 (31.1) 18 (60.0)
Hypertension
Yes 69 (76.7) 22 (73.3)
No 21 (23.3) 8 (26.7)
Hyperlipidaemia
Yes 77 (85.6) 24 (80.0)
No 13 (14.4) 6 (20.0)
Medication
OHA 70 (77.8) 13 (36.7)
OHA þ insulin 14 (15.5) 11 (43.3)
Insulin 6 (6.7) 6 (20.0)
BMI (kg/m2)
<23 12 (25.0) 4 (25.0)
23 78 (75.0) 26 (75.0)
SBP (mmHg) 130 (17.2)a 143.9 (26.5)a
DBP (mmHg) 77 (8.8)a 83.0 (10.2)a
HbA1c (%) 8.6 (2.49)a 10.0 (1.95)a
TC (mmol/L) 4.9 (1.26)a 5.9 (2.02)a
LDL (mmol/L) 2.6 (1.01)a 3.1 (1.17)a
TG (mmol) 1.7 (0.91)a 2.2 (1.73)a
HDL (mmol/L) 1.2 (0.30)a 1.4 (0.26)a
Abbreviation: HbA1c ¼Glycosylated hemoglobin; BMI ¼ Body
mass index; FBS ¼ Fasting blood sugar; TC ¼ Total cholesterol;
TG ¼ Triglyceride; LDL ¼ Low density lipoprotein; HDL ¼
High density lipoprotein, SBP ¼ systolic blood pressure,
DBP ¼ diastolic blood pressure, OHA ¼ oral hypoglycemic
agent.
a Mean (SD).
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distribution) within 1 year before or after the first fundus
photography was considered to be diabetic neuropathy.
Screening for diabetic neuropathy using a microfilament
was not routinely performed in the study centre.
There was no systematic grading of diabetic foot ulcers
documented in the medical record. Consequently, any
documentation of a diabetic foot ulcer within 1 year before
or after the first fundus photography was considered to be
evidence of a diabetic foot.
Stroke was considered if a stroke had occurred within 1
year before or after the first fundus photography. Any
documentation of cardiac events, such as acute coronary
syndrome, arrhythmia, heart failure or significant ECG
changes, that occurred during follow-up within 1 year before
or after the first fundus photography was considered to be
evidence of coronary artery disease.
We estimated a sample size of 30 patients in the PDR
group based on a power of 80%, an a of 0.05 and a reduction
rate of 10%.16 Using random sampling, a ratio of 3:1 was
used for the recruitment of the control group (Type 2 DM
with no DR or normal fundus) for a total of 90 patients.
Study procedure
The list of patients who received fundus photography
from January 2008 until December 2012 was obtained from
the fundus camera book record at the Diabetic Clinic,
HUSM. Fundus photographs were divided into 3 groups: no
DR, PDR and other findings. Information on patient socio-
demographics, diabetic complications (neuropathy, ne-
phropathy, stroke, and cardiovascular disease), glycaemic
control (HbA1c), and cardiovascular risk factors (body mass
index, blood pressure, lipids, and smoking history) were
collected from the patients’ medical records and cross-
checked with the database of the HUSM laboratories.
Statistical analysis
Statistical analyses were performed using the Statistical
Program for Social Sciences (SPSS version 22.0). For the
descriptive analysis, numerical variables are described as the
mean and standard deviation. Categorical data are presented
as the frequency and percentage. Simple logistic regression
analysis was used to assess the significance of variables in
predicting the outcomes. Significant variables with a p value
of <0.25 were then assessed via multivariable analysis by
using multiple logistic regression.
The study protocol was approved in 2013 by the Research
and Ethics Committee, School of Medical Sciences, Uni-
versiti Sains Malaysia. This study was conducted in accor-
dance with the principles set forth by the 18thWorldMedical
Assembly (Helsinky, 1964) and all subsequent amendments.
The patients’ personal identification and clinical data were
kept confidential, and data were reported as collective
information.
Result
A total of 4341 fundus photos of patients were reviewed.
There were 33 patients with PDR, 2952 patients with no DRor a normal fundus, and 1356 patients with other findings.
One-hundred-twenty patients were suitable for the study, of
which 90 had with no DR and 33 had PDR. However,
medical reports were missing for 3 patients with PDR,
leaving 30 patients in the final PDR group.
The mean (SD) age of patients with no DR and PDR was
57 years (12.3) and 52 years, respectively (7.9). There were
more females in the PDR group (53.3%) compared with the
no DR group (45.6%). The majority of patients were Malay
(n ¼ 98), while the non-Malay ethnic group was in the mi-
nority (n ¼ 22). The majority of the no DR patients were
non-smokers (84.4%) and had type 2 DM for less than 10
years (68.9%). A total of 60.0% of patients in the PDR
group had type 2 DM for more than 10 years. Hypertension
(76.7% in no DR and 73.3% in PDR) and hyperlipidaemia
(85.6% in no DR and 80.0% in PDR) were the most com-
mon comorbidities. Systolic blood pressure (SBP) and
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group than in the no DR group. Poor diabetic control
(HbA1c level >6.5%) and high LDL levels (>2.6 mmol/L)
were more common in the PDR group. However, the body
mass index (BMI) for both groups was similar (Table 1).
With reference to diabetic complications, the majority of
patients in the PDR group had nephropathy (56.7%) and
peripheral neuropathy (76.9%) compared with those in the
no DR group (7.8% and 24.4%, respectively) (Table 2). Age
(p ¼ 0.032), duration of DM (p ¼ 0.022), nephropathy
(p ¼ 0.002) and peripheral neuropathy (p ¼ 0.001) were
significantly associated with PDR (Table 3).
Discussion
In this study, age, duration of diabetes, nephropathy and
peripheral neuropathy were significantly associated with
PDR. The mean age of patients with PDR was 52 years old,
which is younger than that reported by M.C. Boelter et al.,
who reported that the average age of patients with PDR was
60.3(9.9) years.16 In the latter study, age was not associated
with PDR, although blood pressure and glucose levels were
poorly controlled, with a mean HbA1c of 10%. Patients
with high HbA1c are prone to a worsening of retinopathy
compared with patients with low HbA1c levels.5 PDR in
our study developed much earlier compared with that
studied by Boelter et al. The relatively young age of patients
with PDR in our study has a significant socioeconomic
impact because this age is considered to be working age.
Therefore, for this age group, issues such as proper
treatment, compliance, diet control and follow-up present
major obstacles. These difficulties result in prolonged hyper-
glycaemia and an increased severity of diabetic eye disease.
Consequently, the incidence of blindness among patients with
diabetes is more common in this age group.17
Our study also revealed that a duration of DM of more
than 10 years is significantly associated with PDR. This
finding is consistent with the results from a local study con-
ducted in Sarawak in which the presence and severity of dia-
betic retinopathy correlatedwith the length of time the patientTable 2: Distribution of diabetic complications in no DR and
PDR group.
Variables No DR (n ¼ 90) PDR (n ¼ 30)
n (%) n (%)
Nephropathy
Yes 7 (7.80) 17 (56.7)
No 83 (92.2) 13 (43.3)
Peripheral neuropathy
Yes 22 (24.4) 23 (76.9)
No 68 (75.6) 7 (23.3)
Diabetic foot
Yes 0 (0.0) 5 (16.7)
No 90 (100.0) 25 (83.3)
Coronary artery disease
Yes 8 (8.9) 1 (3.3)
No 82 (91.1) 29 (96.7)
Stroke
Yes 3 (3.3) 0 (0)
No 87 (96.7) 30 (100)had been diagnosed with DM.18 Persistent hyperglycaemia
leads to an increase in protein kinase activity and the
formation of glycation end products (AGEs). Elevated
protein kinase activity, in turn, leads to an increase in the
permeability of retinal vessels, alteration of retinal blood
flow, basement membrane thickening and increased levels of
vascular endothelial growth factor leading to ocular
neovascularization.19,20 Furthermore, increased formation
of AGEs causes the formation of micro-aneurysms and loss
of capillary endothelium.21 All of these factors contribute to
the progression of diabetic retinopathy from NPDR and
PDR. The prevalence of PDR varies from 1.2% to 67% in
individuals with DM less than 10 years and those with DM
for 35 or more years, respectively.22
Nephropathy is significantly associated with PDR. Pa-
tients who develop severe diabetic retinopathy are prone to
develop diabetic nephropathy.18 Based on Diabetic
Nephropathy Malaysian CPG, the diagnosis of diabetic
nephropathy is made by the presence of proteinuria,
defined as UACR >30 mg/g. However, in this study,
because UACR is not routinely performed, the presence of
proteinuria was based on the positive results of dipsticks
on 2 separate occasions. In a study involving non-insulin
dependent patients with DM, Salvage et al. also found that
increased urine albumin excretion was associated with an
increased prevalence of diabetic retinopathy. Furthermore,
urine albumin excretion was an indicator of renal disease and
generalized vascular damage.23
In this study, approximately 76.9% of patients with PDR
had peripheral neuropathy, consistent with the observation
by Dyck PJ et al. that severe retinopathy is associated with
neuropathy.24 Therefore, patients with PDR should undergo
a complete neurologic examination to exclude diabetic
peripheral neuropathy. Boulton AJ et al. reported that
15% of people with diabetes who develop foot ulcers
develop peripheral neuropathy (nerve damage) and/or
ischaemia (lack of blood supply).25 Neuropathy leads to a
loss of sensation and muscular control and can cause a
variety of other abnormalities and symptoms, such as pain.
Despite the association between peripheral neuropathy and
PDR, we did not demonstrate an association between
diabetic foot and PDR. This is because a foot examination
during follow up was not routinely performed, leading to
under-reporting. In addition, the number of patients is too
small to be able to arrive at a valid conclusion. For these
reasons, the relationship between diabetic foot and PDR
cannot be properly evaluated.
We reviewed 4341 fundus photos of patients with type 2
DM. Thirty-three patients were noted to have PDR as a
result of this routine yearly screening. This finding reflects the
poor metabolic control among patients with type 2 DM
during follow up at Hospital USM. Therefore, data from this
study can serve as a reference point for promoting better
diabetic care in the future. Additional research should also be
conducted to identify the underlying factors contributing to
type 2 DM.Conclusion
Age, duration of diabetes >10 years, nephropathy and
peripheral neuropathy are significantly associated with PDR.
Table 3: Associated factors for no DR and PDR group.
Variable SLR MLR P value
Crude ORa (95%CI)b P value Adjust ORa (95%CI)b Wald stat
Age (years) 0.96 (0.92, 0.99) 0.022 0.92 (0.86,0.94) 0.08 0.032
SBP (mmHg) 1.03 (1.01, 1.05) 0.003
DBP (mmHg) 1.07 (1.01, 1.13) 0.011
TC (mmol/L) 1.54 (1.15, 2.06) 0.004
LDL (mmol/L) 1.42 (0.98, 2.07) 0.070
Gender
Male 1.00
Female 1.37 (0.60, 3.13) 0.461
Race
Non-Malay 1.00
Malay 1.164 (0.39, 3.48) 0.785
Smoking
Non-Smoker 1.00
Smoker 2.71 (1.05, 7.01) 0.039
Duration of DM
<10 year 1.00
>10 year 3.32 (1.41, 7.82) 0.006 5.21 (1.26, 21.48) 1.65 0.022
Hypertension
No 1.00
Yes 0.837 (0.33, 2.15) 0.712
Hyperlipidaemia
No 1.00
Yes 0.68 (0.232, 1.97) 0.472
Nephropathy
No 1.00
Yes 15.80 (5.39, 44.60) <0.001 10.23 (10.23, 45.72) 2.33 0.002
Peripheral neuropathy
No 1.001
Yes 0.16 (3.84, 26.87) <0.001 14.23 (3.05, 66.42) 2.66 0.001
Coronary artery disease
No 1.00
Yes 0.353 (0.42, 2.95) 0.337
Interaction and multicollinearity was checked.Model assumption were checked by Hosmer Lemeshow Test (p¼ 0.120), Classification table
(93.8%). Backward and forward logistic regression variable selection method was applied.




Predictors of proliferative diabetic retinopathy among patients with type 2 diabetes mellitus in Malaysia 357The use of a non-mydriatic fundus camera as a screening tool
for diabetic retinopathy in patients with DM offers a good
detection rate. Reviewing the fundus photo to determine the
stage of PDR is useful in identifying poor metabolic control
in patients with diabetes.Limitation
In this study, there are several limitations. This is a
retrospective study that relied on medical records. Therefore,
the main problem was the difficulties encountered in tracing
medical records because many of them were not available due
to logistic problems. In addition, there was also the problem
of missing data combined with difficulties in obtaining com-
plete data, such as the duration of diabetes, smoking status,
and the prevalence of peripheral neuropathy.
Unequal ethnic distribution is the other limitation of this
study. This study was performed in HUSM, a tertiary centre
in which the majority of the population is Malay. Thus, the
prevalence of PDR in this study may not be representative ofthat in the larger community and should not be applied to
other ethnic groups.
This study is also subject to referral bias as the number of
patients with PDR and a normal fundus was identified a
priori.
Recommendation
We would like to recommend a prospective cohort
study be conducted with a larger sample size that includes
additional variables, such as compliance, physical activity,
and dietary profile. A determination of the levels of in-
flammatory markers, such as C-reactive protein, and mo-
lecular factors, such as vascular endothelial growth factor
(VEGF), may also provide a better overview of the disease
entity.
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